89 related articles for article (PubMed ID: 29791660)
1. Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer.
Danilovic DLS; Castro G; Roitberg FSR; Vanderlei FAB; Bonani FA; Freitas RMC; Coura-Filho GB; Camargo RY; Kulcsar MA; Marui S; Hoff AO
Arch Endocrinol Metab; 2018 Jun; 62(3):370-375. PubMed ID: 29791660
[TBL] [Abstract][Full Text] [Related]
2. The discovery and development of sorafenib for the treatment of thyroid cancer.
White PT; Cohen MS
Expert Opin Drug Discov; 2015 Apr; 10(4):427-39. PubMed ID: 25662396
[TBL] [Abstract][Full Text] [Related]
3. An upper cervical cord compression secondary to occult follicular thyroid carcinoma metastases successfully treated with multiple radioiodine therapies: A clinical case report.
Dong P; Chen N; Li L; Huang R
Medicine (Baltimore); 2017 Oct; 96(41):e8215. PubMed ID: 29019888
[TBL] [Abstract][Full Text] [Related]
4. Response to sorafenib in a locally advanced oncocytic cell carcinoma of the thyroid.
Pereira A; Parra D; Alvarez M; Rincon O
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38378588
[TBL] [Abstract][Full Text] [Related]
5. Hand-foot syndrome associated with use of sorafenib in a patient with papillary thyroid cancer: a case report.
Velandia-Carrillo C; Wandurraga-Sánchez E; Gómez-Abreo D
BMC Endocr Disord; 2014 Mar; 14():26. PubMed ID: 24641872
[TBL] [Abstract][Full Text] [Related]
6. Unusual 131 I Uptake Caused by Paronychia in a Patient With Papillary Thyroid Cancer.
Yang J; Pan Z; Su X
Clin Nucl Med; 2024 Jul; 49(7):e357-e358. PubMed ID: 38389219
[TBL] [Abstract][Full Text] [Related]
7. Long-term Treatment of Pediatric Metastatic Papillary Thyroid Cancer With Lenvatinib.
Donner JR; DeNardo B; Topor LS
JCEM Case Rep; 2024 Feb; 2(2):luad175. PubMed ID: 38283726
[TBL] [Abstract][Full Text] [Related]
8. Fusion Oncogenes in Patients With Locally Advanced or Distant Metastatic Differentiated Thyroid Cancer.
Ju G; Sun Y; Wang H; Zhang X; Mu Z; Sun D; Huang L; Lin R; Xing T; Cheng W; Liang J; Lin YS
J Clin Endocrinol Metab; 2024 Jan; 109(2):505-515. PubMed ID: 37622214
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant tyrosine kinase inhibitor therapy in locally advanced differentiated thyroid cancer: a single centre case series.
Yeo JJY; Stewart K; Maniam P; Arman S; Srinivasan D; Wall L; MacNeill M; Strachan M; Nixon I
J Laryngol Otol; 2023 Nov; 137(11):1237-1243. PubMed ID: 36946096
[TBL] [Abstract][Full Text] [Related]
10. Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer.
Kim Y; Yun HJ; Choi KH; Kim CW; Lee JH; Weicker R; Kim SM; Park KC
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003602
[TBL] [Abstract][Full Text] [Related]
11. Bilateral follicular thyroid carcinoma with large sternal metastasis: Case report and review of the literature.
Al Hassan MS; El Ansari W; Wali HS; Massad E; Darweesh A; Abdelaal A
Int J Surg Case Rep; 2023 Nov; 112():108973. PubMed ID: 37913668
[TBL] [Abstract][Full Text] [Related]
12. An Era of Advances in Systemic Therapies for Advanced Thyroid Cancer.
Yun KM; Cohen EEW
JCO Oncol Pract; 2024 Mar; ():OP2300747. PubMed ID: 38452309
[TBL] [Abstract][Full Text] [Related]
13. Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening.
Sondorp LHJ; Ogundipe VML; Groen AH; Kelder W; Kemper A; Links TP; Coppes RP; Kruijff S
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33142750
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer.
McFarland DC; Misiukiewicz KJ
Onco Targets Ther; 2014; 7():1291-9. PubMed ID: 25053887
[TBL] [Abstract][Full Text] [Related]
15. Radical resection and improvised manubriosternal reconstruction technique for solitary manubriosternal metastasis from papillary thyroid cancer.
Chaudhry IUH; Cheema A; Aqeel C; Al Haji Z; Alqahtani YA; Abbas A
Int J Surg Case Rep; 2020; 76():278-281. PubMed ID: 33059205
[TBL] [Abstract][Full Text] [Related]
16. Heart failure as first sign of development of cardiac metastases in a patient with diagnosis of papillary thyroid carcinoma on treatment with tyrosine-kinase inhibitors: differential diagnoses and clinical management.
Bruixola G; Segura A; Caballero J; Andrés A; Reche E; Escoín C; Díaz-Beveridge R
Case Rep Oncol; 2014 May; 7(2):591-9. PubMed ID: 25298765
[TBL] [Abstract][Full Text] [Related]
17. 2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer.
Fugazzola L; Elisei R; Fuhrer D; Jarzab B; Leboulleux S; Newbold K; Smit J
Eur Thyroid J; 2019 Oct; 8(5):227-245. PubMed ID: 31768334
[TBL] [Abstract][Full Text] [Related]
18. Stable thyroid cancer in a patient with thoracic aortic aneurysm and MYH11 variation.
Fatourechi V; Swanson AA; Lee RA
Endocrinol Diabetes Metab Case Rep; 2024 Jan; 2024(1):. PubMed ID: 38189791
[TBL] [Abstract][Full Text] [Related]
19. New treatment in advanced thyroid cancer.
Giuffrida D; Prestifilippo A; Scarfia A; Martino D; Marchisotta S
J Oncol; 2012; 2012():391629. PubMed ID: 23133451
[TBL] [Abstract][Full Text] [Related]
20. False-Positive Radioiodine Uptake in the Cervix in a Patient with Thyroid Cancer.
Singh P; Parida GK; Singhal T; Kumar P; Emerson R; Agrawal K
Indian J Nucl Med; 2023; 38(3):270-272. PubMed ID: 38046958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
